Conmed (CNMD) Stock Price

Conmed Price

NYSE·CLOSED
46.26
​
Market closed

Over the last 19 years Conmed grew revenue by 4.0% annually, reaching 1.37 B USD. Earnings per share have grown at 0.3% per year over the last 18 years. For Conmed, the net margin of 3.4% is down versus 6.2% a few years ago. At today's price the dividend yield works out to roughly 1.30%. The payout ratio is around 40% of earnings. The consensus 12-month price target for Conmed is 37.50 USD, about 18.9% below where the stock trades today. Of 12 analysts, 0 rate the stock a buy — an overall Hold consensus.

Conmed stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Conmed business model & stock analysis

Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community.

Frequently asked questions about Conmed

Conmed Corp is a leading global medical technology company. Its business model revolves around offering a wide range of surgical products and services to healthcare professionals worldwide. The company specializes in the development, manufacturing, and marketing of innovative surgical devices and equipment. With a focus on minimally invasive procedures, Conmed Corp aims to enhance patient outcomes and reduce healthcare costs. By providing solutions for areas such as electrosurgery, endosurgery, and orthopedic surgery, Conmed Corp continues to drive advancements in the medical field. This commitment to delivering high-quality products and advancing medical technologies solidifies its position as a trusted industry leader.

Conmed Corp is primarily active in the medical devices industry.

The main competitors of Conmed Corp in the market include Medtronic, Johnson & Johnson, Stryker Corporation, and Smith & Nephew.

Conmed Corp. is a renowned medical technology company with a rich history and strong background. Founded in 1970, Conmed Corp. has been dedicated to providing innovative surgical solutions and equipment to healthcare professionals worldwide. With its headquarters in Utica, New York, the company has grown to become a leading player in the field of minimally invasive procedures. Conmed Corp. offers a wide range of products, including surgical instruments, endoscopic technologies, and electrosurgical systems, designed to enhance patient outcomes and streamline healthcare processes. With a focus on research and development, Conmed Corp. continues to shape the future of surgical advancements and improve the standard of patient care.

Conmed Corp has achieved several significant milestones throughout its history. The company has successfully established itself as a leading global medical technology provider, specializing in surgical devices and equipment. Conmed Corp has expanded its product portfolio and enhanced its research and development efforts to cater to a wide range of medical specialties. The company has also received numerous accolades and recognition for its innovative solutions and commitment to improving patient outcomes. With its relentless dedication to advancing clinical education and training, Conmed Corp has become a trusted name in the healthcare industry, ensuring enhanced surgical techniques and superior patient care.

Conmed Corp is primarily present in various countries and regions across the globe. The company has a significant presence in the United States, where its headquarters is located. Additionally, Conmed Corp has established a strong market presence in Europe, especially in countries like Germany, France, and the United Kingdom. The company also operates in Asian markets, including China and Japan, and has a growing presence in emerging markets such as India and Brazil. Furthermore, Conmed Corp has a global distribution network, allowing its products and services to reach healthcare facilities worldwide.

Conmed Corp represents a commitment to delivering innovative medical solutions. With a strong corporate philosophy centered around the core values of integrity, quality, and customer focus, the company aims to improve patient outcomes. Conmed Corp is dedicated to maintaining high ethical standards, fostering a culture of continuous improvement, and promoting teamwork and collaboration. By combining cutting-edge technology with a patient-centric approach, Conmed Corp strives to provide healthcare professionals with advanced tools and services that address the evolving needs of the medical community.

Analysts currently set an average price target of 37.50 USD for the Conmed stock (median: 37.50 USD), implying -18.9 % versus the latest price. The consensus is based on 12 analyst ratings.

12 analysts currently rate the Conmed stock: 0 recommend buying, 8 holding and 4 selling. For 2026, analysts expect Conmed to generate revenue of 1.37 B USD and earnings per share of 4.55 USD.

Converted at the current exchange rate, the Conmed share trades at 41.21 EUR (46.26 USD).

The Conmed share (CNMD) is listed on 5 stock exchanges, including: NYSE (CNMD), SIX (Zürich) (EC8.SW), Frankfurt (EC8.F), München (EC8.MU), Düsseldorf (EC8.DU).

Conmed Corporation is a multinational provider of medical devices and instruments used in orthopedics, gastroenterology, endoscopy, laparoscopy, and other medical fields. The company is headquartered in Utica, New York, and operates in more than 30 countries. Conmed has a diverse business segment that focuses on three main categories: Surgical Instruments, Endoscopy, and Electrosurgery. These three divisions offer various products tailored to the specific needs of surgeons and other medical professionals. The Surgical Instruments division includes a wide range of products such as scissors, forceps, needle holders, scalpels, retractors, and other specialized surgical instruments. These instruments are used in a variety of surgical procedures to ensure precision and safety. Endoscopy is an increasingly important field of study in medicine. Here, Conmed offers a range of products such as endoscopes, capsule endoscopes, endoscopic ultrasound probes, and endoscopy accessories. Endoscopes allow doctors to examine internal organs and tissues, reducing the costs and risks associated with traditional surgery. The Electrosurgery division includes products such as generators, active electrodes, monopolar instruments, bipolar instruments, and accessories. Electrosurgery is used in many surgical procedures to cut, coagulate, or remove tissue. Conmed's products enable surgeons to quickly and effectively remove tissue without causing damage to healthy tissue. Conmed's products are used by a variety of medical professionals in various medical fields. The company also provides excellent customer support, ensuring that surgeons and medical professionals can receive assistance at any time. Conmed has introduced the following products on the market: - Hall Zimmer Surgical PowerTools: The system offers electrically powered surgical hand drills, saws, grinders, and other surgical instruments for orthopedics. - Edge Bipolar Clamping System: This is a bipolar instrument system with a universal cable that can be used in many different surgical procedures. - PRO360 Digital Laparoscopy System: A complete endoscopic device system that provides clear, high-resolution imaging for laparoscopy. - EndoRotor Medical Endoscopy Cleaner: This device allows endoscopy systems to be cleaned, disinfected, and sterilized in a simpler and more effective way. Conmed has a robust service and support system aimed at maintaining customer trust and loyalty. Furthermore, Conmed continuously strives to acquire new knowledge and improve its technology to provide surgeons and other medical professionals with the best instruments and products to enhance their success rate and patient outcomes. Overall, Conmed has a first-class business model that helps medical professionals make their work more effective and safer. The company puts its expertise and technology at the service of the healthcare community and is committed to the safety of its customers and their patients. Answer: Conmed Corporation is a multinational provider of medical devices and instruments used in various medical fields such as orthopedics, gastroenterology, and endoscopy. The company focuses on three main categories: Surgical Instruments, Endoscopy, and Electrosurgery. They offer a wide range of products tailored to the specific needs of surgeons and other medical professionals. Conmed aims to provide reliable customer support and continuously improve their technology to enhance the success and safety of medical procedures.

The expected revenue of Conmed is 1.37 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Conmed is 141.28 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Conmed is currently 10.16. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Conmed stock.

The price-to-sales ratio (P/S) of Conmed is currently 1.05. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Conmed stock.

The Eulerpool Quality Score for Conmed is 5/10.

The ISIN of Conmed is US2074101013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Conmed is 886793. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Conmed is CNMD. The ticker symbol is used to trade Conmed shares on the stock exchange.

Fair ValueTerminal
47.65 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
352,434.62 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Currency
USD
Initial public offering
Apr 14, 2020
ISIN
US2074101013
Cusip
207410101
Sedol
2216010
Market capitalization
1.44 B USDSmall Cap
52-Week Range
PEG
3.94
P/E ratio
P/Ee 2026
10.20
P/Ee 2027
9.67
P/Ee 2028
8.58
P/Ee 2029
7.57
P/S
P/Se
1.05
EV/EBIT
21.47
P/B Ratio
1.39
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
2.52 %
Dividend
Dividend yield
1.30 %
Est. Dividend Yield
1.73 %
Payout Ratio
39.57 %
Dividend growth Ø5Y
—
Dividend payments per year
4
Dividend paid since
14 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
30.00 %
Last updated Oct 19, 2026, 8:06 PM

Conmed Ticker

DÜSSELDORF · EC8.DUFRANKFURT · EC8.FMUNICH · EC8.MUNEW YORK · CNMDSIX · EC8.SW

Conmed FIGI

CNMD:US · BBG000BFZVH8CNMD:UA · BBG000BFZVP9CNMD:UC · BBG000BFZVZ8CNMD:UN · BBG000BFZWR5CNMD:UP · BBG000BFZWZ6CNMD:UB · BBG000BFZXN7CNMD:UT · BBG000BFZYB8CNMD:UM · BBG000BFZYL7CNMD:UX · BBG000BFZZG0CNMD:UD · BBG000BG02S6CNMD:UF · BBG000BG06F1CNMD:VY · BBG000BG09R2

All fundamentals and in-depth analysis of Conmed

Our stock analysis for Conmed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Conmed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.